Hikma Pharmaceuticals PLC
$22.10
24H
Market Cap
Volume
Supply
Price Chart
About Hikma Pharmaceuticals PLC - HIK.L
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of branded and non-branded generic pharmaceuticals. The company's portfolio includes both injectable and oral medications used in areas such as oncology, cardiovascular, and respiratory health.
What are Hikma Pharmaceuticals PLC's core values and mission statement?
Hikma Pharmaceuticals PLC's core values center around integrity, respect, excellence, and transparency, aimed at fostering trust and ensuring quality in all their operations. Their mission is to provide high quality, affordable medicines to the people who need them.
Who founded Hikma Pharmaceuticals PLC and when?
Hikma Pharmaceuticals PLC was founded by Samih Darwazah in 1978.
Who leads Hikma Pharmaceuticals PLC?
As of the last update, Siggi Olafsson was serving as the Chief Executive Officer of Hikma Pharmaceuticals PLC.
Where is Hikma Pharmaceuticals PLC located, and what is its base country?
Hikma Pharmaceuticals PLC is headquartered in London, United Kingdom, which is its base country.
On which exchanges is Hikma Pharmaceuticals PLC traded?
Hikma Pharmaceuticals PLC is primarily listed on the London Stock Exchange.
Historical data
Hikma Pharmaceuticals PLC (HIK) Price Live Data
The live price of Hikma Pharmaceuticals PLC (HIK) is $22.10, with a trading volume of 255,298 in the last 24 hours. Wrapstocks updates the HIK price in real-time. Hikma Pharmaceuticals PLC is up 0.88% in the last 24 hours. The company has a live market cap of $49,198,591.99 and a supply of 2,226,200 HIK stocks.
Hikma Pharmaceuticals PLC (HIK) is traded on London Stock Exchange, and currently, the market is closed; trading will be resumed in 13 hours and 1 minutes.
